Pacific Biosciences of California, Inc. (PACB)
USD 1.31
(-5.76%)
USD 1.31
(-5.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 200.52 Million | 128.3 Million | 130.51 Million | 78.89 Million | 90.89 Million | 78.62 Million |
| Cost of Revenue | 147.74 Million | 79.26 Million | 71.65 Million | 46.32 Million | 56.31 Million | 53.53 Million |
| Gross Profit | 52.78 Million | 49.03 Million | 58.86 Million | 32.56 Million | 34.57 Million | 25.09 Million |
| Operating Expenses | 392.66 Million | 353.85 Million | 237.02 Million | 136.95 Million | 135.12 Million | 126.08 Million |
| Selling, General and Administrative Expenses | 169.81 Million | 160.85 Million | 124.12 Million | 72.79 Million | 75.49 Million | 63.48 Million |
| Research and Development Expenses | 187.17 Million | 193 Million | 112.89 Million | 64.15 Million | 59.63 Million | 62.59 Million |
| Other Expenses | 30.25 Million | 7.63 Million | 93 Thousand | 2.05 Million | 1.02 Million | 848 Thousand |
| Cost and Expenses | 534.98 Million | 433.12 Million | 308.67 Million | 183.27 Million | 191.43 Million | 179.61 Million |
| Operating Income | -334.46 Million | -304.81 Million | -178.16 Million | -104.38 Million | -100.54 Million | -100.98 Million |
| Interest Expense | 14.34 Million | 14.69 Million | 12.53 Million | 267 Thousand | 2.61 Million | 2.42 Million |
| Income Tax Expense | -11.42 Million | -17.31 Million | -93.64 Million | -6.98 Million | -6.31 Million | 848 Thousand |
| Earnings before Tax | -318.15 Million | -314.24 Million | -274.87 Million | 29.4 Million | -84.13 Million | -102.56 Million |
| Net Income | -306.73 Million | -296.93 Million | -181.22 Million | 29.4 Million | -77.81 Million | -102.56 Million |
| Earnings Per Share Basic | -1.21 | -1.32 | -0.89 | 0.18 | -0.51 | -0.76 |
| Earnings Per Share Diluted | -1.21 | -1.32 | -0.89 | 0.17 | -0.51 | -0.76 |
| Weighted Average Shares Outstanding | 253.62 Million | 224.46 Million | 203.62 Million | 172.95 Million | 152.52 Million | 134.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 253.62 Million | 224.55 Million | 204.13 Million | 174.97 Million | 152.52 Million | 135.09 Million |
| Gross Margin | 0.26 | 0.38 | 0.45 | 0.41 | 0.38 | 0.32 |
| EBIT Margin | -1.38 | -2.32 | -1.36 | -1.30 | -1.09 | -1.27 |
| Profit Margin | -1.53 | -2.31 | -1.39 | 0.37 | -0.86 | -1.30 |
| EBITDA | -277.28 Million | -282.24 Million | -250.75 Million | 38.97 Million | -71.57 Million | -92.92 Million |
| Earnings Before Tax Margin | -1.67 | -2.38 | -1.37 | -1.32 | -1.11 | -1.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 36.01 Million | 38.81 Million | 58.35 Million | 200.52 Million | 55.69 Million | 47.57 Million |
| Cost of Revenue | 32.32 Million | 34.38 Million | 47.35 Million | 160.17 Million | 37.78 Million | 32.02 Million |
| Gross Profit | 3.68 Million | 4.42 Million | 11 Million | 40.34 Million | 17.9 Million | 15.54 Million |
| Operating Expenses | 68.3 Million | 85.86 Million | 97.38 Million | 350.71 Million | 91.68 Million | 86.74 Million |
| Selling, General and Administrative Expenses | 35.71 Million | 42.4 Million | 45.99 Million | - | 43.43 Million | 40.57 Million |
| Research and Development Expenses | 32.58 Million | 43.45 Million | 44.54 Million | - | 47.51 Million | 46.17 Million |
| Other Expenses | 6.06 Million | 6.75 Million | -6.84 Million | 32.68 Million | 8.5 Million | 8.92 Million |
| Cost and Expenses | 100.63 Million | 120.24 Million | 144.74 Million | 510.88 Million | 129.47 Million | 118.77 Million |
| Operating Income | -64.61 Million | -81.43 Million | -86.38 Million | -310.36 Million | -82.49 Million | -73.17 Million |
| Interest Expense | 3.54 Million | 3.57 Million | 3.57 Million | 14.34 Million | 3.58 Million | 3.55 Million |
| Income Tax Expense | - | 11.97 Million | -718 Thousand | -11.42 Million | -10.7 Million | 1.57 Million |
| Earnings before Tax | -173.31 Million | -78.17 Million | -82.73 Million | -318.15 Million | -77.57 Million | -69.83 Million |
| Net Income | -173.31 Million | -78.17 Million | -82.01 Million | -306.73 Million | -66.86 Million | -69.83 Million |
| Earnings Per Share Basic | -0.64 | -0.29 | -0.31 | - | -0.26 | -0.28 |
| Earnings Per Share Diluted | -0.64 | -0.29 | -0.31 | - | -0.26 | -0.28 |
| Weighted Average Shares Outstanding | 272.38 Million | 269.57 Million | 267.12 Million | 253.62 Million | 255 Million | 249.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 272.38 Million | 269.57 Million | 267.12 Million | 253.62 Million | 255 Million | 250.07 Million |
| Gross Margin | 0.10 | 0.11 | 0.19 | 0.20 | 0.32 | 0.33 |
| EBIT Margin | -1.40 | -1.79 | -1.48 | - | -1.16 | -1.31 |
| Profit Margin | -4.81 | -2.01 | -1.41 | -1.53 | -1.20 | -1.47 |
| EBITDA | -50.32 Million | -69.41 Million | -86.38 Million | - | -64.53 Million | -62.27 Million |
| Earnings Before Tax Margin | -1.79 | -2.10 | -1.48 | -1.55 | -1.48 | -1.54 |
8942
MPL
STRR
MANVF
002681
NMDC